40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-58.58%
Both yoy net incomes decline, with CNQ at -222.86%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-11.88%
Negative yoy D&A while CNQ is 48.97%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-49.67%
Negative yoy deferred tax while CNQ stands at 75.44%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
314.29%
SBC growth well above CNQ's 4.27%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-259.32%
Both reduce yoy usage, with CNQ at -804.76%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-113.10%
AR is negative yoy while CNQ is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-259.32%
Both reduce yoy usage, with CNQ at -804.76%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
163.89%
Well above CNQ's 121.05%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-47.13%
Negative yoy CFO while CNQ is 23.41%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
40.11%
Some CapEx rise while CNQ is negative at -10.64%. John Neff would see competitor possibly building capacity while we hold back expansions.
-120.00%
Negative yoy acquisition while CNQ stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-115.60%
Negative yoy purchasing while CNQ stands at 100.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
1691.67%
Liquidation growth of 1691.67% while CNQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
40.11%
Growth well above CNQ's 46.90%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
20.47%
Investing outflow well above CNQ's 4.92%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-93.57%
Both yoy lines negative, with CNQ at -8.47%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.